Determination of Three Isoforms of the Receptor Activator of Nuclear Factor-κΒ Ligand and Their Differential Expression in Bone and Thymus* (original) (raw)
Journal Article
,
1_Department of Pathology and Immunology (T.I., M.U., K.H.), Aging and Developmental Science, Graduate School, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519, Japan_
*Address all correspondence and requests for reprints to: Tohru Ikeda, Department of Pathology and Immunology, Aging and Developmental Science, Graduate School, Tokyo Medical and Dental University, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Search for other works by this author on:
,
2_Department of Bacterial and Blood Products (M.K.), National Institute of Infections Diseases, Shinjuku-ku, Tokyo 162, Japan_
Search for other works by this author on:
,
1_Department of Pathology and Immunology (T.I., M.U., K.H.), Aging and Developmental Science, Graduate School, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519, Japan_
Search for other works by this author on:
1_Department of Pathology and Immunology (T.I., M.U., K.H.), Aging and Developmental Science, Graduate School, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519, Japan_
Search for other works by this author on:
Cite
Tohru Ikeda, Michiyuki Kasai, Masanori Utsuyama, Katsuiku Hirokawa, Determination of Three Isoforms of the Receptor Activator of Nuclear Factor-κΒ Ligand and Their Differential Expression in Bone and Thymus, Endocrinology, Volume 142, Issue 4, 1 April 2001, Pages 1419–1426, https://doi.org/10.1210/endo.142.4.8070
Close
Navbar Search Filter Mobile Enter search term Search
Abstract
The receptor activator of nuclear factor (NF)-κB ligand [RANKL; also known as tumor necrosis factor-related activation-induced cytokine, osteoprotegerin ligand, and osteoclast differentiation factor] is known to bind with the receptor activator of NF-κB (RANK) and act not only as a key factor for osteoclastogenesis but also as a regulator of lymphocyte development. In this study, we found two additional isoforms of RANKL. RANKL 2 has a shorter intracellular domain than the original RANKL (RANKL 1), and RANKL 3 lacks a transmembrane domain and was thought to act as a soluble form. In the bone marrow stromal cell line ST2 and preosteoblastic cell line MC3T3-E1, all three RANKL isoforms were detected, but the expression of RANKL 2 was preferentially suppressed by treatment with 1α,25-dihydroxyvitamin D3 and dexamethasone. In young adult thymus, CD4−CD8− double-negative cells were positive for all three isoforms, CD4+CD8+ double-positive cells were positive for RANKL 1 and RANKL 3 but negative for RANKL 2, and CD4+CD8− and CD4−CD8+ single-positive cells were positive for all three isoforms. Immunofluorescence analyses of NIH3T3 cells transfected with each RANKL isoform indicated that the three RANKL isoforms were translated, and RANKL 2 protein predominantly stayed in the endoplasmic reticulum and Golgi networks. These results indicate that there are three kinds of RANKL-RANK pathways. The presence of multiple RANKL-RANK pathways suggests a more complicated RANKL-RANK system for osteoclastogenesis or T cell differentiation than previously thought.
Copyright © 2001 by The Endocrine Society
You do not currently have access to this article.
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
- Click Sign in through your institution.
- Select your institution from the list provided, which will take you to your institution's website to sign in.
- When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
- Click Sign in through society site.
- When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
- View your signed in personal account and access account management features.
- View the institutional accounts that are providing access.
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
Purchase
Short-term Access
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
Determination of Three Isoforms of the Receptor Activator of Nuclear Factor-κΒ Ligand and Their Differential Expression in Bone and Thymus* - 24 Hours access
EUR €38.00
GBP £33.00
USD $41.00
Rental
This article is also available for rental through DeepDyve.
Citations
Views
Altmetric
Metrics
Total Views 1,810
1,194 Pageviews
616 PDF Downloads
Since 2/1/2017
Month: | Total Views: |
---|---|
February 2017 | 4 |
March 2017 | 7 |
April 2017 | 11 |
May 2017 | 3 |
June 2017 | 14 |
July 2017 | 13 |
August 2017 | 5 |
September 2017 | 5 |
October 2017 | 8 |
November 2017 | 2 |
December 2017 | 20 |
January 2018 | 18 |
February 2018 | 17 |
March 2018 | 12 |
April 2018 | 10 |
May 2018 | 13 |
June 2018 | 16 |
July 2018 | 14 |
August 2018 | 17 |
September 2018 | 18 |
October 2018 | 10 |
November 2018 | 12 |
December 2018 | 13 |
January 2019 | 20 |
February 2019 | 14 |
March 2019 | 32 |
April 2019 | 42 |
May 2019 | 21 |
June 2019 | 9 |
July 2019 | 15 |
August 2019 | 34 |
September 2019 | 32 |
October 2019 | 27 |
November 2019 | 22 |
December 2019 | 20 |
January 2020 | 38 |
February 2020 | 11 |
March 2020 | 26 |
April 2020 | 18 |
May 2020 | 8 |
June 2020 | 14 |
July 2020 | 10 |
August 2020 | 20 |
September 2020 | 30 |
October 2020 | 13 |
November 2020 | 19 |
December 2020 | 16 |
January 2021 | 25 |
February 2021 | 13 |
March 2021 | 21 |
April 2021 | 22 |
May 2021 | 23 |
June 2021 | 20 |
July 2021 | 12 |
August 2021 | 16 |
September 2021 | 14 |
October 2021 | 13 |
November 2021 | 20 |
December 2021 | 7 |
January 2022 | 16 |
February 2022 | 18 |
March 2022 | 25 |
April 2022 | 27 |
May 2022 | 30 |
June 2022 | 26 |
July 2022 | 31 |
August 2022 | 31 |
September 2022 | 37 |
October 2022 | 47 |
November 2022 | 20 |
December 2022 | 30 |
January 2023 | 15 |
February 2023 | 15 |
March 2023 | 16 |
April 2023 | 34 |
May 2023 | 36 |
June 2023 | 16 |
July 2023 | 14 |
August 2023 | 30 |
September 2023 | 10 |
October 2023 | 26 |
November 2023 | 27 |
December 2023 | 11 |
January 2024 | 22 |
February 2024 | 35 |
March 2024 | 22 |
April 2024 | 25 |
May 2024 | 23 |
June 2024 | 31 |
July 2024 | 28 |
August 2024 | 17 |
September 2024 | 24 |
October 2024 | 16 |
×
Email alerts
Related articles in PubMed
Citing articles via
More from Oxford Academic